( 6 ) One study showed that, over a 56-week study of 100 obese men on a reduced calorie diet, men who received testosterone injections improved weight loss by 6.4 pounds over men who received no such treatment
Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials
Prevents Type 2 Diabetes Progression By improving insulin sensitivity and beta-cell function Supports Cardiovascular Health Reduces blood pressure, LDL cholesterol, and inflammation Lowers Risk of Fatty Liver Disease (NAFLD/NASH) Helps reduce liver fat accumulation Improves PCOS Symptoms Regulates ovulation, insulin resistance, and weight in women with PCOS May Benefit Neuroprotection Early studies suggest a role in reducing neuroinflammation and cognitive decline Contraindications These GLP-1s are generally well-tolerated, but some patients should not take them
For comparison of continuous variables in different time points, Friedman (comparison of three time points) and Wilcoxon signed-rank test for related samples with post hoc Bonferroni corrections for multiple comparisons (comparison of two time points) were used
Long COVID: does SARS-CoV-2 induce lingering brain lesions
Adhesion molecules of the endothelial cells make contacts with monocytes which later invade the vascular wall and differentiate into macrophages
.png)
